| 000 | 01791 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515022839.0 | ||
| 264 | 0 | _c20060608 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0893-8512 | ||
| 024 | 7 |
_a10.1128/CMR.19.2.338-381.2006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScollard, D M | |
| 245 | 0 | 0 |
_aThe continuing challenges of leprosy. _h[electronic resource] |
| 260 |
_bClinical microbiology reviews _cApr 2006 |
||
| 300 |
_a338-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xmetabolism |
| 650 | 0 | 4 | _aBacterial Vaccines |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDisease Susceptibility _ximmunology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aGenes, Bacterial _xgenetics |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenome, Bacterial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 |
_aImmunity, Innate _xgenetics |
| 650 | 0 | 4 |
_aLeprostatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLeprosy _xdiagnosis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMycobacterium leprae _xchemistry |
| 650 | 0 | 4 |
_aPeripheral Nerves _xmicrobiology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xmicrobiology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aSchwann Cells _ximmunology |
| 700 | 1 | _aAdams, L B | |
| 700 | 1 | _aGillis, T P | |
| 700 | 1 | _aKrahenbuhl, J L | |
| 700 | 1 | _aTruman, R W | |
| 700 | 1 | _aWilliams, D L | |
| 773 | 0 |
_tClinical microbiology reviews _gvol. 19 _gno. 2 _gp. 338-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/CMR.19.2.338-381.2006 _zAvailable from publisher's website |
| 999 |
_c16219148 _d16219148 |
||